As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...

Vasomotor symptoms are a common problem in women with HR-positive breast cancer receiving anti-cancer therapy.

Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

I did not finish that yoga class. Instead, I rolled up my mat and fled the studio for the air-conditioned bathroom where I ...

Menopause is a natural biological process that marks the end of a woman's menstrual cycles, typically occurring in the late ...

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

Both cognitive-behavioral therapy and clinical hypnosis are among the most effective options not involving medication.

Veozah is an oral, neurokinin 3 receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. The labeling for the product now includes a boxed warning ...

SSRIs and selective norepinephrine reuptake inhibitors (SNRIs) have been extensively studied for the management of hot flashes with varying results. [1] In this well-done trial, escitalopram at ...

Most hot flashes are caused by hormonal changes, but they can also be related to other health conditions, substances, and even certain treatments or medications. The intensity and frequency of hot ...